Eir Diagnostics ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark

 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  5.5% 2.8% 2.3% 2.8% 2.4%  
Credit score (0-100)  42 59 63 59 62  
Credit rating  BBB BBB BBB BBB BBB  
Credit limit (kDKK)  0.0 0.0 0.1 0.0 0.1  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  660 1,455 1,216 1,649 1,061  
EBITDA  -328 -473 -662 -843 -424  
EBIT  -328 -473 -662 -866 -481  
Pre-tax profit (PTP)  -423.8 -612.2 -668.8 -986.1 -730.9  
Net earnings  -326.6 -368.6 -469.0 -594.0 -507.1  
Pre-tax profit without non-rec. items  -424 -612 -669 -986 -731  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  0.0 0.0 0.0 285 254  
Shareholders equity total  249 5,205 7,434 7,589 7,562  
Interest-bearing liabilities  3,193 0.0 0.0 2,014 3,157  
Balance sheet total (assets)  3,905 6,385 8,815 11,589 12,566  

Net Debt  2,024 -1,166 -1,093 1,477 3,087  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  660 1,455 1,216 1,649 1,061  
Gross profit growth  0.0% 120.5% -16.4% 35.5% -35.7%  
Employees  0 0 3 4 3  
Employee growth %  0.0% 0.0% 0.0% 33.3% -25.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  3,905 6,385 8,815 11,589 12,566  
Balance sheet change%  0.0% 63.5% 38.1% 31.5% 8.4%  
Added value  -327.8 -473.1 -662.0 -865.8 -423.8  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  2,409 2,174 2,564 3,077 1,700  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  -1.0 -2.0 -3.0 -4.0 -5.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  -49.7% -32.5% -54.4% -52.5% -45.4%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  -8.4% -9.2% -8.7% -8.5% -4.0%  
ROI %  -9.1% -10.1% -9.5% -9.1% -4.3%  
ROE %  -131.4% -13.5% -7.4% -7.9% -6.7%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  6.4% 81.5% 84.3% 65.5% 60.2%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -617.5% 246.4% 165.1% -175.3% -728.5%  
Gearing %  1,284.7% 0.0% 0.0% 26.5% 41.7%  
Net interest  0 0 0 0 0  
Financing costs %  6.0% 8.7% 0.0% 11.9% 9.7%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  5.2 2.7 3.2 0.5 0.2  
Current Ratio  5.2 2.7 3.2 0.5 0.2  
Cash and cash equivalent  1,168.5 1,165.6 1,093.2 537.1 69.7  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  1,209.2 1,133.1 1,144.6 -1,174.3 -2,778.2  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 -221 -216 -141  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 -221 -211 -141  
EBIT / employee  0 0 -221 -216 -160  
Net earnings / employee  0 0 -156 -148 -169